Moderna's mRNA flu vaccine shows stronger immune response
posted a day ago
“Finally, a virus worth giving a hug.”
Moderna announced that its experimental mRNA-based flu vaccine generated a stronger immune response compared to the current vaccine in a late-stage trial. This promising data paves the way for further development of both the flu vaccine and a combination shot for flu and Covid-19.